RESPONSE TO INFUSIONS OF POLY-ELECTROLYTE FRACTIONATED HUMAN FACTOR-VIII CONCENTRATE IN HUMAN HEMOPHILIA-A AND VONWILLEBRANDS DISEASE

被引：161
|
作者：
TUDDENHAM, EGD
LANE, RS
ROTBLAT, F
JOHNSON, AJ
SNAPE, TJ
MIDDLETON, S
KERNOFF, PBA
机构：
[1] NYU MED CTR, DEPT MED, NEW YORK, NY 10016 USA
[2] BLOOD PROD LAB, ELSTREE, HERTS, ENGLAND
[3] SCH MED, LONDON, ENGLAND
[4] SPEYWOOD LABS LTD, NOTTINGHAM, ENGLAND
[5] CHURCHILL HOSP, PLASMA FRACTIONAT LAB, OXFORD OX3 7LJ, ENGLAND
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1982年 / 52卷 / 02期
关键词：
D O I：
10.1111/j.1365-2141.1982.tb03888.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 267
页数：9
相关论文
共 50 条
  • [41] CRYOPRECIPITATE AND FACTOR-VIII CONCENTRATE (AHF) INFUSION - STUDY OF A VARIANT VONWILLEBRANDS DISEASE PATIENT
    THOMAS, KB
    HOWARD, MA
    FIRKIN, BG
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (05) : 525 - 526
  • [42] HUMAN FACTOR-VIII - PURIFICATION FROM COMMERCIAL FACTOR-VIII CONCENTRATE, CHARACTERIZATION, IDENTIFICATION AND RADIOLABELING
    HAMER, RJ
    KOEDAM, JA
    BEESERVISSER, NH
    SIXMA, JJ
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 873 (03) : 356 - 366
  • [43] CLINICAL-EVALUATION OF RECOMBINANT HUMAN FACTOR-VIII (BAY-W-6240) IN THE TREATMENT OF HEMOPHILIA-A
    FUKUI, H
    YOSHIOKA, A
    SHIMA, M
    TANAKA, I
    KOSHIHARA, K
    FUKUTAKE, K
    FUJIMAKI, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1991, 54 (05) : 419 - 427
  • [44] DEVELOPMENT AND ANALYSIS OF RETROVIRAL VECTORS EXPRESSING HUMAN FACTOR-VIII AS A POTENTIAL GENE-THERAPY FOR HEMOPHILIA-A
    CHUAH, MKL
    VANDENDRIESSCHE, T
    MORGAN, RA
    HUMAN GENE THERAPY, 1995, 6 (11) : 1363 - 1377
  • [45] COMPARISON OF ANTI-HUMAN AND ANTIPORCINE FACTOR-VIII INHIBITOR LEVELS IN 63 PATIENTS WITH SEVERE HEMOPHILIA-A
    FIKSSIGAUD, M
    BENDELAC, L
    PARQUET, A
    VERROUST, F
    TORCHET, MF
    BERTHIER, AM
    FRESSINAUD, E
    GUEROIS, C
    AILLAUD, MF
    BONEU, B
    DERLON, A
    SUBTIL, E
    BERTRAND, MA
    BORG, JY
    LAURIAN, Y
    VOX SANGUINIS, 1993, 64 (04) : 210 - 214
  • [46] TREATMENT OF HEMOPHILIA-A WITH A HIGHLY PURIFIED FACTOR-VIII CONCENTRATE PREPARED BY ANTI-FVIIIC IMMUNOAFFINITY CHROMATOGRAPHY
    ADDIEGO, JE
    GOMPERTS, E
    LIU, SL
    BAILEY, P
    COURTER, SG
    LEE, ML
    NESLUND, GG
    KINGDON, HS
    GRIFFITH, MJ
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 19 - 27
  • [47] GENE-THERAPY FOR HEMOPHILIA-A - PRODUCTION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-VIII IN-VIVO IN MICE
    DWARKI, VJ
    BELLONI, P
    NIJJAR, T
    SMITH, J
    COUTO, L
    RABIER, M
    CLIFT, S
    BERNS, A
    COHEN, LK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 1023 - 1027
  • [48] CLINICAL AND BIOLOGICAL EVALUATION IN VONWILLEBRANDS DISEASE OF A VONWILLEBRAND-FACTOR CONCENTRATE WITH LOW FACTOR-VIII ACTIVITY
    GOUDEMAND, J
    MAZURIER, C
    MAREY, A
    CARON, C
    COUPEZ, B
    MIZON, P
    GOUDEMAND, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) : 214 - 221
  • [49] VIRUS-INACTIVATED FACTOR-VIII CONCENTRATE PREVENTS POSTOPERATIVE BLEEDING IN A PATIENT WITH VONWILLEBRANDS DISEASE
    FURLAN, M
    LAMMLE, B
    AEBERHARD, A
    KIRSTE, E
    SULZER, I
    TRANSFUSION, 1988, 28 (05) : 489 - 492
  • [50] USE OF A HIGH-PURITY FACTOR-VIII CONCENTRATE (HEMATE-P) IN VONWILLEBRANDS DISEASE
    BERNTORP, E
    NILSSON, IM
    VOX SANGUINIS, 1989, 56 (04) : 212 - 217
12345